AI Science Tracker
EN

The role of mitochondrial energy metabolism in drug resistance and prognosis of lung adenocarcinoma: a multi-omics and machine learning strategy for predictive and personalized therapy.

Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University; School of Medicine, Northwest University; Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University · 31 Jul 2026 · medicine

Discovery

The role of mitochondrial energy metabolism in drug resistance and prognosis of lung adenocarcinoma: a multi-omics and machine learning strategy for predictive and personalized therapy.

Source check: Source checked. Not independent scientific confirmation.

Finding: Using single-cell RNA-sequencing and TCGA-LUAD data, the authors built a five-gene LASSO-Cox prognostic classifier, MDrisk, from mitochondrial-metabolism and drug-resistance features. Scores were associated with immune and tumor-genomic features and computationally inferred drug sensitivity; ALDOA silencing was followed by reduced lung-adenocarcinoma cell proliferation, migration and invasion in vitro. This does not show patient treatment benefit.

Technology: The MDrisk five-gene prognostic classifier was selected using LASSO-Cox and combinations of machine-learning algorithms applied to mitochondrial-metabolism and drug-resistance features.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The MDrisk five-gene prognostic classifier was selected using LASSO-Cox and combinations of machine-learning algorithms applied to mitochondrial-metabolism and drug-resistance features.
Test and result
The primary article reports MDrisk development from single-cell RNA-sequencing and TCGA-LUAD data, assessment in training, internal-test and external GEO cohorts, associations with immune and tumor-genomic features, and computationally inferred drug sensitivity. In vitro ALDOA silencing experiments assessed lung-adenocarcinoma cell proliferation, migration and invasion. Drug sensitivity was computationally inferred; the study did not test whether MDrisk-guided therapy improves patient outcomes.
Limitation / still unknown
Drug sensitivity was computationally inferred, and cell experiments do not establish clinical treatment benefit or patient outcomes.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13472987/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.